Anti-VSV-G [IE9F9] Antibody

The IE9F9 (I14) monoclonal antibody reacts with VSV-G protein from the Indiana serotype, and has been successfully used in experiments with VSV-G TS045.

Vesicular stomatitis virus (VSV) is a well studied, enveloped, negative-strand RNA virus. The VSV genome encodes for 5 proteins: N, P, M, G, and L. The G protein (glycoprotein) is located at the virion surface and is responsible for virus attachment and penetration. Additionally, many lentivrial vectors are pseudotyped with VSV-G from the Indiana serotype.

From the laboratory of Douglas S. Lyles, PhD, Wake Forest School of Medicine.

The Investigator's Annexe Part of The Investigator's Annexe program.

Catalog Number Product Size AVAILABILITY Price Qty
Anti-VSV-G [IE9F9] Antibody, 100 ug
100ug (1mg/mL) In stock
Price: $356.00
Product Type: Antibody
Name: anti-VSV-G (IE9F9)
Host: Mouse
Isotype: IgG2a kappa
Clonality: Monoclonal
Clone Name: Ie9F9 (I14)
Specificity: VSV-Ind glycoprotein (G) protein
Immunogen: VSV infection
Format: Liquid
Purity: Protein G purified
Buffer: 0.1M Sodium Phosphate, pH 7.4, 0.15M NaCl, 0.05% (w/v) Sodium Azide
Tested Applications: Western blot (1:1000)
Concentration: 1mg/mL
Amount: 100uL
Storage: -20C (avoid repeated freeze / thaw cycles)
Shipped: Cold packs
From the laboratory of Douglas S. Lyles, PhD, Wake Forest School of Medicine.
  1. Vandepol SB, Lefrancois L, Holland JJ. Sequences of the Major Anitbody Binding Epitopes of the Indiana Serotype of Vesicular Stomatitis Virus. Virology 148: 312-325 (1986).
  2. Lefrancios L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121: 157-167, 1982.
  3. Genevini P, Papiani G, Ruggiano A, Cantoni L, Navone F, Borgese N. Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model. PLoS One. 2014 Nov 19;9(11):e113416. doi: 10.1371/journal.pone.0113416. View Article
  4. Yonemura Y, Li X, Müller K, Krämer A, Atigbire P, Mentrup T, Feuerhake T, Kroll T, Shomron O, Nohl R, Arndt HD, Hoischen C, Hemmerich P, Hirschberg K, Kaether C. Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06. J Cell Sci. 2016 Oct 15;129(20):3868-3877. PubMed PMID: 27587840.View Article
  5. Fossati M, Colombo SF, Borgese N. A positive signal prevents secretory membrane cargo from recycling between the Golgi and the ER. EMBO J. 2014 Sep 17;33(18):2080-97. doi: 10.15252/embj.201488367. PubMed PMID: 25063674; PubMed Central PMCID: PMC4195774. View Article
  6. Tezuka K, Okuma K, Kuramitsu M, Matsuoka S, Tanaka R, Tanaka Y, Hamaguchi I. Control of HTLV-1 Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. J Virol. 2017 Dec 6. pii: JVI.01885-17. View Article
  7. Tam AB, Roberts LS, Chandra V, Rivera IG, Nomura DK, Forbes DJ, Niwa M. The UPR Activator ATF6 Responds to Proteotoxic and Lipotoxic Stress by Distinct Mechanisms. Dev Cell. 2018 Aug 6. View Article

If you publish research with this product, please let us know so we can cite your paper.